The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 03, 2015

Filed:

Apr. 08, 2009
Applicants:

John Myers Zanella, Cordova, TN (US);

Christopher M. Hobot, Tonka Bay, MN (US);

Danielle L. Biggs, Collierville, TN (US);

Katara Shaw, Birmingham, AL (US);

Phillip Edward Mcdonald, Plymouth, MN (US);

Vanja Margareta King, Memphis, TN (US);

William F. Mckay, Memphis, TN (US);

Kathy L. Remsen, Germantown, TN (US);

Inventors:

John Myers Zanella, Cordova, TN (US);

Christopher M. Hobot, Tonka Bay, MN (US);

Danielle L. Biggs, Collierville, TN (US);

Katara Shaw, Birmingham, AL (US);

Phillip Edward McDonald, Plymouth, MN (US);

Vanja Margareta King, Memphis, TN (US);

William F. McKay, Memphis, TN (US);

Kathy L. Remsen, Germantown, TN (US);

Assignee:

Warsaw Orthopedic, Inc., Warsaw, IN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A01N 43/50 (2006.01); A61K 31/415 (2006.01); A61K 31/4162 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 47/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4162 (2013.01); A61K 9/0024 (2013.01); A61K 9/204 (2013.01); A61K 47/34 (2013.01);
Abstract

Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain, as well as pain that is incidental to surgery. When appropriate formulations are provided within biodegradable polymers, this relief can be continued for at least three days. In some embodiments, the relief can be for at least twenty-five days, at least fifty days, at least one hundred days, at least one hundred and thirty-five days or at least one hundred and eighty days.


Find Patent Forward Citations

Loading…